Evidence map›Paper›PMID 30760706›Full record

ArticleNature communications2019

Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.

Marilia Rita Pinzone, D Jake VanBelzen, Sam Weissman, Maria Paola Bertuccio, LaMont Cannon, Emmanuele Venanzi-Rullo, Stephen Migueles, R Brad Jones, Talia Mota, Sarah B Joseph and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 1 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 1 synthesis or guideline pooled it, 189 citations in OpenAlex.

  1. Pooled it
  2. Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People With HIV at 48 Weeks.Journal of acquired immune deficiency syndromes (1999) · 2026
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Marilia Rita PinzoneDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
D Jake VanBelzenDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.ORCID http://orcid.org/0000-0003-0949-3641
Sam WeissmanDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Maria Paola BertuccioDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
LaMont CannonDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Emmanuele Venanzi-RulloDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.ORCID http://orcid.org/0000-0001-8273-5382
Stephen MiguelesLaboratory of Immunoregulation, National Institutes of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, 20892, MD, USA.
R Brad JonesInfectious Disease Division, Weill Cornell Medical College, New York, 10065, NY, USA.
Talia MotaInfectious Disease Division, Weill Cornell Medical College, New York, 10065, NY, USA.
Sarah B JosephDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, 27599, NC, USA.
Kevin GroenLaboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, The Netherlands.
Alexander O PasternakLaboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, 1105, The Netherlands.ORCID http://orcid.org/0000-0002-4097-4251
Wei-Ting HwangDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Brad ShermanLaboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratories for Cancer Research, Leidos Biomedical Research Inc., supporting the Division of Clinical Research, NIAID, Frederick, 21702, MD, USA.
Anastasios VourekasDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.ORCID http://orcid.org/0000-0002-1850-5635
Giuseppe NunnariDepartment of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Messina, Messina, 98124, Italy.
Una O'DohertyDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA. unao@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0001-7464-8369
University of Pennsylvania · USAmsterdam UMC Location University of Amsterdam · NLCornell University · USUniversity of Messina · ITLeidos (United States) · USNational Institutes of Health · USNorthwestern University · USUniversity of North Carolina at Chapel Hill · US

Funding

BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral EradicationUM1AI126617 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI JONES, R. BRAD, NIXON, DOUGLAS F · 2016 to 2020
$28.1M
Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI126619 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2016 to 2020
$23.2M
Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitroR37AI150556 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Una T O'Doherty · 2020 to 2026
$4.2M
HIV Evolution Defines Virus-Host/Drug Interactions In Viremic and Aviremic PeopleR01AI140970 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ronald I Swanstrom, Shuntai Zhou · 2018 to 2026
$4.1M
A FAST Assay to Quantify HIV ReservoirsR01AI120011 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI O'DOHERTY, UNA T, SAMBUCETTI, LIDIA C · 2015 to 2019
$3.1M
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cellsR33AI104280 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI RILEY, JAMES L. · 2015 to 2017
$1.4M
Unveiling the chromosomal address of intact HIV clones to provide insights into persistenceR21AI143564 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI O'DOHERTY, UNA T · 2019 to 2020
$457k
An ex vivo model to predict outcomes and probe mechanism of anti-reservoir agentsR21AI116216 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI O'DOHERTY, UNA T · 2014 to 2015
$440k
NIAID NIH HHS R01 AI120011NIAID NIH HHS R01 AI140970NIAID NIH HHS R21 AI116216NIAID NIH HHS R21 AI143564NIAID NIH HHS R33 AI104280NIAID NIH HHS R37 AI150556NIAID NIH HHS UM1 AI126617NIAID NIH HHS UM1 AI126619NIH HHS R01AI12001NIH HHS R01-AI140970NIH HHS R21AI116216NIH HHS R33AI104280NIH HHS UM1AI126617
6 · The paper itself

Abstract

After initiating antiretroviral therapy (ART), a rapid decline in HIV viral load is followed by a long period of undetectable viremia. Viral outgrowth assay suggests the reservoir continues to decline slowly. Here, we use full-length sequencing to longitudinally study the proviral landscape of four subjects on ART to investigate the selective pressures influencing the dynamics of the treatment-resistant HIV reservoir. We find intact and defective proviruses that contain genetic elements favoring efficient protein expression decrease over time. Moreover, proviruses that lack these genetic elements, yet contain strong donor splice sequences, increase relatively to other defective proviruses, especially among clones. Our work suggests that HIV expression occurs to a significant extent during ART and results in HIV clearance, but this is obscured by the expansion of proviral clones. Paradoxically, clonal expansion may also be enhanced by HIV expression that leads to splicing between HIV donor splice sites and downstream human exons.

Indexed as

Antiretroviral Therapy, Highly ActiveAdultAntiviral AgentsFemaleHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedMutationPhylogenyProvirusesViral LoadViremiaAntiviral Agents

Identifiers

PMID30760706
PMCPMC6374386
OpenAlexW2914054854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.